LOS ANGELES--(BUSINESS WIRE)--Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Kitov Pharmaceutical Holdings Ltd. (“Kitov” or the “Company”) (Nasdaq: KTOV) concerning possible violations of federal securities laws.
On February 6, 2017, the Israeli publication Calcalist revealed that Kitov’s Chief Executive Officer, Isaac Israel, had been held by the Israeli Securities Authority regarding allegations of publishing misleading information about a recent clinical trial of one of Kitov’s products. When this information was disclosed to the investing public, the value of Kitov stock fell, causing investors harm.
Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.